Hammarén E, Yli-Hankala A, Rosenberg P H, Hynynen M
Department of Anaesthesia, Helsinki University Hospital, Finland.
Br J Anaesth. 1996 Sep;77(3):360-4. doi: 10.1093/bja/77.3.360.
Unbound, rather than total, plasma concentrations may be related to the anaesthetic action of propofol. Therefore, we measured plasma concentrations of propofol and recorded Nb wave latencies of auditory evoked potentials (AEP) during continuous infusion of propofol in 15 patients undergoing coronary artery bypass grafting (CABG) surgery. After induction of anaesthesia with fentanyl, propofol was infused continuously at a rate of 10 mg kg-1 h-1 for 20 min, and then the rate was reduced to 3 mg kg-1 h-1. Administration of heparin before cardiopulmonary bypass (CPB) did not affect total or unbound propofol concentration. Initiation of CPB decreased mean total propofol concentration from 2.6 to 1.7 micrograms ml-1 (P < 0.01). Simultaneously, mean unbound propofol concentration remained at 0.06 micrograms ml-1 because of a slight increase in the mean free fraction of plasma propofol (from 2.3 to 3.5%; P > 0.05). During hypothermic CPB, mean total propofol concentration increased to concentrations measured before bypass (to 2.1 micrograms ml-1; P > 0.05 vs value before CPB) and the mean unbound propofol concentration was at its highest (0.07 microgram ml-1; P < 0.05 vs value before heparin). After CPB and administration of protamine, the mean total propofol concentration remained lowered (1.7 micrograms ml-1; P < 0.05 vs value before heparin) and the mean unbound propofol concentration returned to the level measured before heparin (P < 0.001 vs value during hypothermia). The latency of the Nb wave from recordings of AEP increased after induction of anaesthesia, reached its maximum during hypothermia and was prolonged during the subsequent phases of the study. The latency of the Nb wave did not correlate with total or unbound propofol concentration. We conclude that the changes in total and unbound concentrations of plasma propofol were not parallel in patients undergoing CABG. During CPB or at any other time during the CABG procedure, the unbound propofol concentration did not decrease and Nb wave latency was prolonged compared with baseline values measured after induction of anaesthesia before the start of CPB.
与丙泊酚麻醉作用相关的可能是游离而非总血浆浓度。因此,我们在15例接受冠状动脉搭桥术(CABG)的患者持续输注丙泊酚期间,测量了丙泊酚的血浆浓度,并记录了听觉诱发电位(AEP)的Nb波潜伏期。在用芬太尼诱导麻醉后,丙泊酚以10mg·kg-1·h-1的速率持续输注20分钟,然后速率降至3mg·kg-1·h-1。在体外循环(CPB)前给予肝素不影响丙泊酚的总浓度或游离浓度。CPB开始时,丙泊酚平均总浓度从2.6微克/毫升降至1.7微克/毫升(P<0.01)。同时,丙泊酚平均游离浓度保持在0.06微克/毫升,因为血浆丙泊酚的平均游离分数略有增加(从2.3%至3.5%;P>0.05)。在低温CPB期间,丙泊酚平均总浓度升至CPB前测量的浓度(至2.1微克/毫升;与CPB前的值相比P>0.05),且丙泊酚平均游离浓度最高(0.07微克/毫升;与肝素前的值相比P<0.05)。CPB及给予鱼精蛋白后,丙泊酚平均总浓度仍较低(1.7微克/毫升;与肝素前的值相比P<0.05),且丙泊酚平均游离浓度恢复至肝素前测量的水平(与低温期间的值相比P<0.001)。麻醉诱导后,AEP记录中Nb波的潜伏期增加,在低温期间达到最大值,并在研究的后续阶段延长。Nb波潜伏期与丙泊酚总浓度或游离浓度无关。我们得出结论,在接受CABG的患者中,血浆丙泊酚总浓度和游离浓度的变化并不平行。在CPB期间或CABG手术的任何其他时间,与CPB开始前麻醉诱导后测量的值相比,丙泊酚游离浓度未降低且Nb波潜伏期延长。